EMBC

Embecta Corp. Healthcare - Medical Instruments & Supplies Investor Relations →

YES
51.4% BELOW
↑ Moving away Was -53.7% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $13.29
14-Week RSI 68
Rel. Volume (14w) This week's trading vs. the 14-week average 0.7x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.23

Embecta Corp. (EMBC) closed at $6.46 as of 2026-11-13, trading 51.4% below its 200-week moving average of $13.29. This places EMBC in the extreme value zone. The stock moved further from the line this week, up from -53.7% last week. The 14-week RSI sits at 68, indicating neutral momentum.

Trading volume is running at 0.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.23 ratio) is neutral — neither side is clearly dominating.

Over the past 194 weeks of data, EMBC has crossed below its 200-week moving average 1 time. On average, these episodes lasted 190 weeks.

With a market cap of $366 million, EMBC is a small-cap stock. The company generates a free cash flow yield of 37.8%, which is notably high. The stock trades at -0.6x book value.

Share count has increased 2.5% over three years, indicating dilution.

Over the past 3.8 years, a hypothetical investment of $100 in EMBC would have grown to $23, compared to $200 for the S&P 500. EMBC has returned -31.7% annualized vs 19.8% for the index, underperforming the broader market over this period.

Free cash flow has been declining at a -22.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: EMBC vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After EMBC Crosses Below the Line?

Across 1 historical episodes, buying EMBC when it crossed below its 200-week moving average produced an average return of -51.0% after 12 months (median -51.0%), compared to +30.0% for the S&P 500 over the same periods. After 24 months, the average return was -54.0% vs +40.0% for the index.

Each line shows $100 invested at the moment EMBC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Dislocation Scores Experimental

Each score measures deviation from EMBC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

2 stacked signals: sector, value_vs_history
Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +0.78σ Distance from line vs own history
Sector-Relative +1.73σ Vs sector median this week
Buyback Acceleration +0.6pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 86th TTM buys / market cap, percentile of buyers
FCF Yield vs History +27.0pp Vs own recent annual mean
Earnings Quality Improving Accrual gap trend (-12.0pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

EMBC has crossed below its 200-week MA 1 time

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Mar 2023Ongoing190+80.6%Ongoing-73.8%

Frequently Asked Questions

Is EMBC below its 200-week moving average?

Yes. As of 2026-11-13, Embecta Corp. (EMBC) is trading 51.4% below its 200-week moving average of $13.29. The current price is $6.46.

What is EMBC's 200-week moving average price?

Embecta Corp.'s 200-week moving average is $13.29 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when EMBC drops below its 200-week moving average?

EMBC has crossed below its 200-week moving average 1 time in our data. These episodes lasted 190 weeks on average.

Is EMBC a good value right now?

Here's what our data says about EMBC as of 2026-11-13: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 68. Free cash flow yield is 37.8%. Price-to-book is -0.6x. This is not a buy or sell recommendation — always do your own research.

How does EMBC compare to the S&P 500?

Over the past 3.8 years, $100 invested in EMBC would have grown to $23, compared to $200 for the S&P 500. That's -31.7% annualized vs 19.8% for the index. EMBC has underperformed the broader market over this period.

Does EMBC pay a dividend?

Yes. Embecta Corp. currently pays a dividend yield of 62.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13